A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma

Stopped early · Phase 1

Conditions studied: Non-Hodgkin Lymphoma

In brief

This study evaluates the safety, tolerability, PK, and preliminary efficacy of AZD0466 as monotherapy or in combination with other anticancer agents in patients with advanced NHL

Key facts

Study ID

NCT05205161

Run by

AstraZeneca

People needed

7

Starts

2022-07-05

Expected to finish

2023-08-17

Last updated by the study team

2025-01-07

Who can join

Age: 18 and older, up to 130. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Research Site — Duarte, California, United States
• Research Site — Heidelberg, Australia
• Research Site — Lille, France
• Research Site — Milan, Italy
• Research Site — Porto, Portugal
• Research Site — Seoul, South Korea
• Research Site — Seoul, South Korea
• Research Site — Palma de Mallorca, Spain
• Research Site — Pamplona, Spain
• Research Site — Salamanca, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.